1. Fondazione IRCCS, Foundation Policlinico Universitario Agostino Gemelli IRCCS, Istituto Nazionale dei Tumori, Milan, Italy;
2. MANGO and Europen Institute of Oncology, Milan, Italy;
3. The University of Texas MD Anderson Cancer Center, Houston, TX;
4. Massey Cancer Center, Virginia Commonwealth University, Richmond, VA;
5. University of Virginia, Charlottesville, VA;
6. Peking Union Medical College Hospital, Beijing, China;
7. Saitama Medical University International Medical Center, Hidaka, Japan;
8. Federal University of Minas Gerais Brazil and Brazilian Group of Gynecologic Oncology, Belo Horizonte, Brazil;
9. Grand Hôpital de Charleroi, Prague, Czech Republic;
10. Nordic Society of Gynaecological Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark;
11. Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), CITOHL, EMR UCBL/HCL 3738, Lyon, GINECO & GINEGEPS, Lyon, France;
12. Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain;
13. UZ Leuven, Leuven, Belgium;
14. TRSGO and Koc University School of Medicine, Istanbul, Turkey;
15. Department of Gynecology, Charité Medical University, Berlin, Germany;
16. Sheba Medical Center, Tel Aviv University, Tel Hashomer, Israel;
17. Department of Gynecology and Obstetrics, Medical University of Innsbruck, Innsbruck, Austria;
18. Merck & Co., Inc., Kenilworth, NJ;
19. MSD United Kingdom, UK, United Kingdom;
20. Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione “G. Pascale”, Naples, Italy;